| For: | Miao YR, Yang XJ. Hepatocellular carcinoma resistance to tyrosine kinase inhibitors: Current status and perspectives. World J Gastrointest Oncol 2025; 17(4): 101528 [PMID: 40235904 DOI: 10.4251/wjgo.v17.i4.101528] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v17/i4/101528.htm |
| Number | Citing Articles |
| 1 |
Xiyang Sheng, Longbo Wang, Gengyuan Shi, Yongzhao Li, Dongdong Wang, Wei Wang, Yongyue Du, Siyang Wang, Chen Mi, Hanteng Yang. Efferocytosis as a Metabolic Rheostat: The Metabolic Bridge connecting TKI-induced cell death to immune tolerance in hepatocellular carcinoma. Critical Reviews in Oncology/Hematology 2026; 223 doi: 10.1016/j.critrevonc.2026.105355
|
| 2 |
Xian-Bin Huang, Yuan Deng, Shi-Yi Gong, Miao Yu, Hui Cai. <i>ASAP3</i> disrupts <i>ASAP1</i>-<i>ARHGAP12</i> to inhibit <i>RhoA</i> and yes-associated protein/transcriptional coactivator with <i>PDZ</i>-binding motif, suppressing gastric cancer progression. World Journal of Gastrointestinal Oncology 2026; 18(8): 117876 doi: 10.4251/wjgo.v18.i8.117876
|